BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1738011)

  • 1. Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy.
    Bromberg MB; Feldman EL; Jaradeh S; Albers JW
    J Clin Epidemiol; 1992 Jan; 45(1):47-52. PubMed ID: 1738011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies.
    Pollard JD
    Muscle Nerve; 1987; 10(3):214-21. PubMed ID: 3031499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy; different beneficial effects and their correlation to the clinical features.
    Kumazawa K; Sobue G; Yamamoto K; Kitano M; Nakamura S; Kato K; Mitsuma T
    Intern Med; 1995 Jun; 34(6):537-41. PubMed ID: 7549138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of inflammatory neuropathy.
    Hughes RA; Gabriel CM; Gregson NA; Smith KJ
    Mult Scler; 1997 Apr; 3(2):88-92. PubMed ID: 9291160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyradiculoneuropathy.
    Mendell JR
    Annu Rev Med; 1993; 44():211-9. PubMed ID: 8476243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy.
    Kimura K; Nezu A; Kimura S; Otsuki N; Kobayashi T; Nomura Y; Segawa M
    Neuropediatrics; 1998 Apr; 29(2):108-12. PubMed ID: 9638666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    Van Doorn PA
    Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.
    Barnett MH; Pollard JD; Davies L; McLeod JG
    Muscle Nerve; 1998 Apr; 21(4):454-60. PubMed ID: 9533779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
    Simmons Z; Albers JW; Bromberg MB; Feldman EL
    Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy.
    De Luca G; Lugaresi A; Iarlori C; Marzoli F; Di Iorio A; Gambi D; Uncini A
    J Neuroimmunol; 1999 Mar; 95(1-2):190-4. PubMed ID: 10229130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.
    Dyck PJ; Daube J; O'Brien P; Pineda A; Low PA; Windebank AJ; Swanson C
    N Engl J Med; 1986 Feb; 314(8):461-5. PubMed ID: 3511382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
    Hanaoka N; Hanyu N; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):208-12. PubMed ID: 9711115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of plasma exchange on indices of demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.
    Ashworth NL; Zochodne DW; Hahn AF; Pillay N; Chalk C; Benstead T; Bril V; Feasby TE; Bolton CF
    Muscle Nerve; 2000 Feb; 23(2):206-10. PubMed ID: 10639612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.
    McCombe PA; Pollard JD; McLeod JG
    Brain; 1987 Dec; 110 ( Pt 6)():1617-30. PubMed ID: 3427403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rapid improvement of nerve conduction in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Saito Y; Yokota T
    Rinsho Shinkeigaku; 1993 Oct; 33(10):1066-9. PubMed ID: 8293607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.
    Hahn AF; Bolton CF; Pillay N; Chalk C; Benstead T; Bril V; Shumak K; Vandervoort MK; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1055-66. PubMed ID: 8813270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kumazawa K; Yuasa N; Mitsuma T; Nagamatsu M; Sobue G
    Rinsho Shinkeigaku; 1998 Aug; 38(8):719-23. PubMed ID: 9916516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.